Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Prostate cancer is associated with high mortality among men. Old age, heredity, life>

Statistics:

North America and Europe minimally invasive prostate cancer surgery market is estimated to account for US$ 86,187.4 Mn in terms of value by the end of 2027.

North America and Europe Minimally Invasive Prostate Cancer Surgery Market: Drivers

Increasing prevalence of prostate cancer is expected to propel growth of North America and Europe minimally invasive prostate cancer surgery market over the forecast period. For instance, according to the American Cancer Society, in 2019, there will be around 174,650 men with newly diagnosed prostate cancer in the U.S., registering a 6% increase from 2018.

Moreover, increasing geriatric population is also expected to aid in growth of the market. For instance, according to the U.S. Census Bureau, the U.S. geriatric population is expected to reach 77 million by 2034.     

Statistics:

North America held dominant position in North America and Europe minimally invasive prostate cancer surgery market in 2019, accounting for 60.6% share in terms of value, followed by Europe, respectively.

Figure 1: North America and Europe Minimally Invasive Prostate Cancer Surgery Market Share (%) Value, By Region, 2019

North America and Europe Minimally Invasive Prostate Cancer Surgery  | Coherent Market Insights

North America and Europe Minimally Invasive Prostate Cancer Surgery Market: Restraints

Inefficiency of surgery in treating advanced stage cancer is expected to hinder growth of North America and Europe minimally invasive prostate cancer surgery market. Surgical procedure is more suitable when the cancer is localized within the prostate gland. However, as the cancer metastases to nearby lymph nodes and bones, surgery becomes incapable of treating it.

Moreover, many surgeons are hesitant in adopting the new robotic technology and prefer the traditional methods, which is also expected to limit the market growth.

request-sample

North America and Europe Minimally Invasive Prostate Cancer Surgery Market Report Coverage

Report Coverage Details
Base Year: 2019 Market Size in 2019: US$ 34,960.2 Mn
Historical Data for: 2016 to 2019 Forecast Period: 2020 to 2027
Forecast Period 2020 to 2027 CAGR: 11.9% 2027 Value Projection: US$ 86,187.4 Mn
Geographies covered:
  • North America: U.S., Canada
  • Europe: Germany, U.K., France, Spain, Italy, Russia, Rest of Europe
Segments covered:
  • By Product Type:
    • Hand: Resectoscope, Linear Cutter, Insufflators, Curved Stapler, Endoscopic Trocars, Prostatic Retractor, Cryoablation Device, Others.
    • Monitoring & Visualization: Cameras & Video Support, Endoscopic Trocars with Optical View.
    • Powered: Electrosurgical Unit, Lasers.
  • By Application: Laparoscopy, Robotics Surgery, Brachytherapy, Cryosurgery.
Companies covered:

Angiodynamics, Inc., Profound Medical, BSD Medical Corporation, Medtronic Plc, Ethicon Endo-Surgery, Inc., Olympus Corporation, Siemens Healthcare, Intuitive Surgical, Inc., and Teleflex, Inc.

Growth Drivers:
  • Increasing prevalence of prostate cancer
  • Approval and launch of new products
Restraints & Challenges:
  • High Cost of treatment
  • Product recall

Statistics:

North America and Europe minimally invasive prostate cancer surgery market was valued at US$ 34,960.2 Mn in 2019 and is forecast to reach a value of US$ 86,187.4 Mn by 2027 at a CAGR of 11.9% between 2020 and 2027.

Figure 2: North America and Europe Minimally Invasive Prostate Cancer Surgery Market Value (US$ Mn), 2016 – 2027

North America and Europe Minimally Invasive Prostate Cancer Surgery  | Coherent Market Insights

Market Trends/Key Takeaways

Major players in the market are focused on raising funds to expand their product portfolio. For instance, in September 2019, Profound Medical raised around US$ 8 million to cover a reimbursement study and a Tulsa-Pro clinical trial, building out its sales & marketing infrastructure, R&D and other general corporate purposes.

Major players in the market are focused on R&D of new products to expand their product portfolio. For instance, in October 2018, NeoTract announced that a study evaluating its UroLift (permanent implants, delivered during a minimally invasive transurethral outpatient procedure) treatment for men with enlarged prostate glands showed a 62% improvement in lower urinary tract symptoms.

North America and Europe Minimally Invasive Prostate Cancer Surgery Market: Competitive Landscape

Major players operating in North America and Europe minimally invasive prostate cancer surgery market include, Angiodynamics, Inc., Profound Medical, BSD Medical Corporation, Medtronic Plc, Ethicon Endo-Surgery, Inc., Olympus Corporation, Siemens Healthcare, Intuitive Surgical, Inc., and Teleflex, Inc.

North America and Europe Minimally Invasive Prostate Cancer Surgery Market: Key Developments

Major players in the market are focused on approval and launch of new products to expand their product portfolio. For instance, in February 2018, NeoTract, a subsidiary of Teleflex, Inc., received expanded indications from the U.S. FDA for its UroLift prostate treatment.

Major players in the market are also focused on raising funds to expand their product portfolio. For instance, in February 2018, Procept BioRobotics raised UU$ 118 million in an equity round to commercialize its Aquablation treatment for benign prostate hyperplasia.

Prostate cancer is associated with high mortality among men. The major factors increasing the risk of the disease constitute of old age, heredity, lifestyle aspects such as smoking and diet rich in red meat. Cancer- digital rectal exam (DRE), prostate biopsy, prostate specific antigen (PSA) blood test, bone scan, ultrasound, CT scan, MRI, lymph node biopsy and ProstaScint monoclonal antibody scan are generally used for diagnosis of prostate cancer. Laparoscopy, cryosurgery, brachytherapy and robotic surgery are the commonly practices surgical techniques while performing minimally invasive surgeries for the treatment of prostate cancer. Factors such as increasing prevalence of prostate cancer, increasing product approvals, and increasing investment in research and development are expected to propel the market growth during the forecast period.

Key features of the study:

  • This report provides in-depth analysis of the North America and Europe Minimally Invasive Prostate Cancer Surgery market  and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2020–2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the North America and Europe Minimally Invasive Prostate Cancer Surgery market  based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, Angiodynamics, Inc., Profound Medical, BSD Medical Corporation, Medtronic Plc, Ethicon Endo-Surgery, Inc., Olympus Corporation, Siemens Healthcare, Intuitive Surgical, Inc., and Teleflex, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The North America and Europe Minimally Invasive Prostate Cancer Surgery market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the North America and Europe Minimally Invasive Prostate Cancer Surgery market

Detailed Segmentation:

  • North America and Europe Minimally Invasive Prostate Cancer Surgery Market, By Product Type:
    • Hand
      • Resectoscope
      • Linear Cutter
      • Insufflators
      • Curved Stapler
      • Endoscopic Trocars
      • Prostatic Retractor
      • Cryoablation Device
      • Others
    • Monitoring & Visualization
      • Cameras & Video Support
      • Endoscopic Trocars with Optical View
    • Powered
      • Electrosurgical Unit
      • Lasers
  • North America and Europe Minimally Invasive Prostate Cancer Surgery Market, By Application:
    • Laparoscopy
    • Robotics Surgery
    • Brachytherapy
    • Cryosurgery
  • North America and Europe Minimally Invasive Prostate Cancer Surgery Market, By Region:
    • North America
      • By Product Type:
        • Hand
          • Resectoscope
          • Linear Cutter
          • Insufflators
          • Curved Stapler
          • Endoscopic Trocars
          • Prostatic Retractor
          • Cryoablation Device
          • Others
        • Monitoring & Visualization
          • Cameras & Video Support
          • Endoscopic Trocars with Optical View
        • Powered
          • Electrosurgical Unit
          • Lasers
      • By Application
        • Laparoscopy
        • Robotics Surgery
        • Brachytherapy
        • Cryosurgery
      • By Country
        • U.S.
        • Canada
    • Europe
      • By Product Type:
        • Hand
          • Resectoscope
          • Linear Cutter
          • Insufflators
          • Curved Stapler
          • Endoscopic Trocars
          • Prostatic Retractor
          • Cryoablation Device
          • Others
        • Monitoring & Visualization
          • Cameras & Video Support
          • Endoscopic Trocars with Optical View
        • Powered
          • Electrosurgical Unit
          • Lasers
      • By Application
        • Laparoscopy
        • Robotics Surgery
        • Brachytherapy
        • Cryosurgery
      • By Country
        • U.K.
        • Germany
        • France
        • Spain
        • Italy
        • Russia
        • Rest of Europe
  • Company Profiles
    • Angiodynamics, Inc. *
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Profound Medical
    • BSD Medical Corporation
    • Medtronic Plc
    • Ethicon Endo-Surgery, Inc.
    • Olympus Corporation
    • Siemens Healthcare
    • Intuitive Surgical, Inc.
    • Teleflex, Inc.
  •  “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Application
      • Market Snippet, By Country
      • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Key Highlights
    • Product launch
    • PEST Analysis
    • Technological Advancements
    • Regulatory Scenario
    • Mergers and Acquisitions
    • Impact of COVID19 on market
  4. North America and Europe Minimally Invasive Prostate Cancer Surgery Market, By Product Type, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Hand
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Resectoscope
        • Linear Cutter
        • Insufflators
        • Curved Stapler
        • Endoscopic Trocars
        • Prostatic Retractor
        • Cryoablation Device
        • Others
    • Monitoring & Visualization
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Cameras & Video Support
        • Endoscopic Trocars with Optical View
    • Powered
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Electrosurgical Unit
        • Lasers
  5. North America and Europe Minimally Invasive Prostate Cancer Surgery Market, By Application, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Laparoscopy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Robotics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Brachytherapy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Cryosurgery
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  6. North America and Europe Minimally Invasive Prostate Cancer Surgery Market, By Region, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2026
    • North America
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Germany
        • U.K.
        • France
        • Spain
        • Italy
        • Russia
        • Rest of Europe
  7. Competitive Landscape
    • Company Profiles
      • Angiodynamics, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Profound Medical
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • BSD Medical Corporation
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Medtronic Plc
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Ethicon Endo-Surgery, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Olympus Corporation
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Siemens Healthcare
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Intuitive Surgical, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Teleflex, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
  8. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 18 market data tables and 14 figures on “Minimally Invasive Prostate Cancer Surgery Market – North America and Europe forecast to 2027”.

Frequently Asked Questions

The North America and Europe Minimally Invasive Prostate Cancer Surgery market size was valued at US$ 34,960.2 million in 2019 and is estimated to exhibit a CAGR of 11.9% between 2020 and 2027.
Monitoring & Visualization segment held the major market share in 2019 owing increasing prevalence of prostate cancer along with increasing demand for minimally invasive procedures is expected to propel growth of the North America and Europe Minimally Invasive Prostate Cancer Surgery market over the forecast period.
Major factor driving the growth of North America and Europe Minimally Invasive Prostate Cancer Surgery market during the forecast period increasing prevalence of prostate cancer, new product launch, and adoption of expansion strategies from major companies.
Major factors hampering the growth of the North America and Europe Minimally Invasive Prostate Cancer Surgery market during the forecast period constitutes of product recalls and high cost associated with treatment.
North America market is expected to generate the highest revenue during the forecast period.
Some of the key players operating in the market are Angiodynamics, Inc., Profound Medical, BSD Medical Corporation, Medtronic Plc, Ethicon Endo-Surgery, Inc., Olympus Corporation, Siemens Healthcare, Intuitive Surgical, Inc., and Teleflex, Inc.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner